Observational Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Dec 15, 2020; 12(12): 1428-1442
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1428
Table 5 Univariate and multivariate analyses for clinical parameters used to predict disease-free survival and overall survival
Variable Disease-free survival
Overall survival
Univariate P valueMultivariate
Univariate P valueMultivariate
HR (95%CI)
P value
HR (95%CI)
P value
Age (< 60 vs ≥ 60 yrs)0.4920.770 (0.255-1.618)0.4920.7290.621 (0.314-1.245)0.177
Sex (female vs male)0.4930.773 (0.375-1.626)0.4930.6780.906 (0.442-1.812)0.783
Location (colon vs rectum)0.3530.216 (0.102-1.231)0.1530.3460.291 (0.054-1.154)0.082
cT stage (T4a vs T4b)0.1272.423 (0.604-9.836)0.2580.2062.611 (0.752-9.054)0.128
cN stage (N0 vs N+)0.1270.690 (0.139-3.014)0.1570.1020.336 (0.094-1.087)0.078
Tumor grade (WD/MD vs PD)0.3350.503 (0.098-1.936)0.4130.4230.840 (0.247-2.500)0.765
CEA (≤ 5 ng/mL vs > 5 ng/mL)0.4181.422 (0.614-3.391)0.3830.5281.219 (0.581-2.622)0.602
Neoadjuvant chemotherapy (FOLFOX vs Capecitabine)0.1423.549 (0.944-7.467)0.0820.1172.846 (0.860-8.715)0.158
Radiation dose (< 50 Gy vs ≥ 50 Gy)0.3510.291 (0.054-1.154)0.1820.3272.525 (0.347-5.843)0.221
Radiation-surgery interval (≤ 9 wk vs > 9 wk)0.0861.236 (0.792-5.276)0.0970.1062.064 (0.589-7.062)0.167
ypT stage (ypT3-4 vs ypT0-2)0.2372.484 (0.744-5.691)0.6360.0972.150 (0.820-6.123)0.121
ypN stage (ypN+ vs ypN0)0.0053.120 (1.245-8.357)0.017a0.0731.771 (0.435-6.255)0.405
Lymphovascular invasion (positive vs negative)0.3632.503 (0.724-7.788)0.1410.1753.046 (0.961-9.081)0.069
Perineural invasion (positive vs negative)0.0722.649 (0.869-8.976)0.0870.0911.222 (0.323-4.078)0.757
Resection margin (positive vs negative)0.0013.549 (1.004-12.747)0.014a0.0134.136 (1.675-10.829)0.001a
Pathological response (non-pCR vs pCR)0.0452.560 (1.186-6.013)0.042a0.0312.977 (1.420-6.369)0.003a